I'm pleased to present this paper we published with CMI recently on the potential use of flomoxef to treat infections caused by OXA-48 producing Enterobacterales.

RT @holland_tom: It’s lucky we have a famously competent state, a well-funded health service, & courts with plenty of time on their hands,…

@APTlivuni @VineetD1509 Also worth highlighting that a lot of the pre-clinical and PK work for this drug was done in the University of Liverpool. @shampadaspkpd @NikkiFarringto1 @NIHRCRF_Lpool 11/11

RT @IDWeekmtg: A seven-day course of antibiotics for hospitalized patients with bloodstream infections is just as effective as a 14-day cou…

RT @doctor_oxford: Very few people realise that the vast majority of hospice and palliative care is provided by charity - not by the NHS.…

RT @Nature: Not for the first time, all Nobel Prizes in scientific disciplines this year have been awarded to men

@kadler42 @DrNeilStone Because the dosing of specific BLIs is tied to the dose and pharmacokinetics of the partner BL. Moreover, pharmacokinetic dissociation is a problem if you seperate the compound into seperate parts.

Thank you to all the co-authors for their hard work with this. @VineetD1509 @Sara_E_Boyd @AleGerada @gardp_amr @APTlivuni